Australian-led research is unlocking new ways for immunotherapy to better target cancer. Cancer immunotherapy has revolutionised treatment for patients, whereby the body's own immune system is ...

Cancer immunotherapy has revolutionized treatment for patients, whereby the body's own immune system is harnessed to destroy cancer cells. Typically, several molecules restrain the ability of T cells ...

Australian-led research is unlocking new ways for immunotherapy to better target cancer. Cancer immunotherapy has ...

EgG1Y162 protein has good antigenicity and immunogenicity and is therefore a good candidate molecule for E. granulosus vaccine. Mature T cells express CTLA-4 on their surface, and its extracellular ...

There's plenty of tech advancements as well, with the Global AI in Oncology Market growing at a rapid 35% CAGR, towards US$13.6 billion by 2032. Analysts at Spherical Insights project the global ...

Instil Bio is a clinical-stage biotech focusing on personalized immunotherapy. Check out my recommendation for TIL stock.

Immune checkpoint inhibitors (ICIs) targeting the cytotoxic T-lymphocyte antigen-4 (CTLA-4), programmed death-1 (PD-1), and ...

At a median follow-up of 31.5 months (range, 6.1 to 48.4), progression-free survival outcomes (the primary analysis) were significantly better with nivolumab plus ipilimumab than with chemotherapy ...

When is the Fable 4 release date? The next installment in the Fable series was finally revealed at the Xbox and Bethesda Showcase back in 2020. Details about the long-awaited sequel have been thin ...

However, more recent studies have suggested that adjuvant therapy with a high-affinity human IgG1 monoclonal antibody, called durvalumab, that binds programmed death ligand 1 could help prolong ...

You are free to share (copy and redistribute) this article in any medium or format and to adapt (remix, transform, and build upon) the material for any purpose, even commercially within the parameters ...